{"transactions":[{"id":730220,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:05:03.000Z","date":"2026-06-18","kind":"sale","planned":false,"acquired":false,"shares":1776,"price":2.71,"value":4812.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2026."}],"balance_after":390247,"source":{"system":"sec-edgar","filing":"0001193125-26-277507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000119312526277507/ownership.xml","form_type":"4"}},{"id":733614,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T21:39:32.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on the earlier of (i) the first anniversary of the vesting commencement date, which was June 9, 2026 or (ii) the registrant's 2027 annual meeting of shareholders."}],"balance_after":31000,"derivative":{"exercise_price":1.75,"expiration_date":"2036-06-16","underlying":"Common Shares","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0000929638-26-002259","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000092963826002259/form4.xml","form_type":"4"}},{"id":935133,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-20T22:39:00.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":26046,"price":2.07,"value":53915.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":390023,"source":{"system":"sec-edgar","filing":"0001193125-26-016865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000119312526016865/ownership.xml","form_type":"4"}},{"id":943089,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-08T22:48:54.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":562000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2026."}],"balance_after":562000,"derivative":{"exercise_price":1.93,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":562000},"source":{"system":"sec-edgar","filing":"0001193125-26-007896","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000119312526007896/ownership.xml","form_type":"4"}},{"id":943088,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T22:48:54.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":94000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in four equal annual installments beginning on January 14, 2027. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2025."}],"balance_after":416069,"source":{"system":"sec-edgar","filing":"0001193125-26-007896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000119312526007896/ownership.xml","form_type":"4"}},{"id":1104787,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-20T20:08:53.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":1790,"price":1.79,"value":3204.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.76 to $1.79. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2025."}],"balance_after":320069,"source":{"system":"sec-edgar","filing":"0000950170-25-088501","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017025088501/ownership.xml","form_type":"4"}},{"id":1109561,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T22:38:50.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option fully vests on the earlier of (i) the first anniversary of the date vesting commenced, which was June 10, 2025; or (ii) the 2026 Annual Meeting of Shareholders.."}],"balance_after":22500,"derivative":{"exercise_price":3.31,"expiration_date":"2035-06-16","underlying":"Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000929638-25-002250","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000092963825002250/form4.xml","form_type":"4"}},{"id":1117557,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:05:57.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":377000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is scheduled to vest and become exercisable as to 40% of the shares subject to the grant on June 5, 2026. The remaining 60% of the shares subject to the grant is scheduled to vest and become exercisable on June 5, 2027."}],"balance_after":377000,"derivative":{"exercise_price":1.83,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":377000},"source":{"system":"sec-edgar","filing":"0000950170-25-083708","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017025083708/ownership.xml","form_type":"4"}},{"id":1299830,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-17T22:35:27.000Z","date":"2025-01-15","kind":"sale","planned":false,"acquired":false,"shares":17378,"price":2.2,"value":38231.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold as required by the applicable award terms to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":319859,"source":{"system":"sec-edgar","filing":"0000950170-25-006824","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017025006824/ownership.xml","form_type":"4"}},{"id":1307747,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T21:05:11.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":565500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2025."}],"balance_after":565500,"derivative":{"exercise_price":2.5,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":565500},"source":{"system":"sec-edgar","filing":"0000950170-25-002827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017025002827/ownership.xml","form_type":"4"}},{"id":1307746,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-07T21:05:11.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":94500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in four equal annual installments beginning on January 14, 2026. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired on May 31, 2024 and 2,000 shares acquired on November 30, 2024, in each case under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":337237,"source":{"system":"sec-edgar","filing":"0000950170-25-002827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017025002827/ownership.xml","form_type":"4"}},{"id":1472919,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-20T21:03:42.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":1770,"price":5.6,"value":9912.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold as required by the applicable award terms to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $5.58 to $5.60. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":240737,"source":{"system":"sec-edgar","filing":"0000950170-24-075732","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017024075732/ownership.xml","form_type":"4"}},{"id":1474839,"issuer":{"id":6638,"kind":"organization","name":"enGene Therapeutics Inc.","symbol":"ENGN"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-18T20:08:51.000Z","date":"2024-06-15","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests at 1/3 on each of the first, second and third anniversaries of the date vesting commenced, which was May 15, 2024."}],"balance_after":40000,"derivative":{"exercise_price":9,"expiration_date":"2034-06-15","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000929638-24-002216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000092963824002216/form4.xml","form_type":"4"}},{"id":1480336,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T22:13:00.000Z","date":"2024-06-12","kind":"grant","planned":true,"acquired":true,"shares":12179,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12179,"derivative":{"exercise_price":28.68,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":12179},"source":{"system":"sec-edgar","filing":"0001396814-24-000075","document":"wk-form4_1718316771.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000139681424000075/wk-form4_1718316771.xml","form_type":"4"}},{"id":1480335,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T22:13:00.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":880,"price":28.38,"value":24974.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":12724,"source":{"system":"sec-edgar","filing":"0001396814-24-000075","document":"wk-form4_1718316771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000139681424000075/wk-form4_1718316771.xml","form_type":"4"}},{"id":1480334,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T22:13:00.000Z","date":"2024-06-12","kind":"grant","planned":true,"acquired":true,"shares":5230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":13604,"source":{"system":"sec-edgar","filing":"0001396814-24-000075","document":"wk-form4_1718316771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000139681424000075/wk-form4_1718316771.xml","form_type":"4"}},{"id":1594903,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:33:51.000Z","date":"2024-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":137642,"price":13.33,"value":1834767.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and most recently amended on June 27, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.00 to $13.85. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":240507,"source":{"system":"sec-edgar","filing":"0000950170-24-026055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017024026055/ownership.xml","form_type":"4"}},{"id":1594902,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:33:51.000Z","date":"2024-03-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12358,"price":13,"value":160654.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and most recently amended on June 27, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.00 to $13.01. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":378149,"source":{"system":"sec-edgar","filing":"0000950170-24-026055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017024026055/ownership.xml","form_type":"4"}},{"id":1676131,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-18T21:40:06.000Z","date":"2024-01-16","kind":"sale","planned":false,"acquired":false,"shares":9697,"price":8.74,"value":84751.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.74 to $8.96. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":390507,"source":{"system":"sec-edgar","filing":"0000950170-24-005426","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000095017024005426/ownership.xml","form_type":"4"}},{"id":1683907,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-08T21:47:30.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":509500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2024."}],"balance_after":509500,"derivative":{"exercise_price":6.01,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":509500},"source":{"system":"sec-edgar","filing":"0001209191-24-001160","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919124001160/doc4.xml","form_type":"4"}},{"id":1683906,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-08T21:47:30.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in four equal annual installments beginning on January 14, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,802 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2023."}],"balance_after":400204,"source":{"system":"sec-edgar","filing":"0001209191-24-001160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919124001160/doc4.xml","form_type":"4"}},{"id":1846287,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-22T20:20:52.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":1704,"price":4.85,"value":8264.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2023."}],"balance_after":313402,"source":{"system":"sec-edgar","filing":"0001209191-23-039051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123039051/doc4.xml","form_type":"4"}},{"id":1851698,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:32:58.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12925,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12925,"derivative":{"exercise_price":38.74,"exercise_date":"2024-06-14","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12925},"source":{"system":"sec-edgar","filing":"0001209191-23-038023","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123038023/doc4.xml","form_type":"4"}},{"id":1851697,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T21:32:58.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":8374,"source":{"system":"sec-edgar","filing":"0001209191-23-038023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123038023/doc4.xml","form_type":"4"}},{"id":1863625,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T01:23:19.000Z","date":"2023-06-05","kind":"sale","planned":false,"acquired":false,"shares":580,"price":38.339,"value":22236.62,"ownership":{"direct":true},"balance_after":6599,"source":{"system":"sec-edgar","filing":"0001209191-23-035257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123035257/doc4.xml","form_type":"4"}},{"id":1888617,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-17T20:07:38.000Z","date":"2023-05-15","kind":"exercise","planned":true,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 12, 2013."}],"balance_after":0,"derivative":{"exercise_price":29.9,"expiration_date":"2023-06-12","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-23-030141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123030141/doc4.xml","form_type":"4"}},{"id":1888616,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T20:07:38.000Z","date":"2023-05-15","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":41.85,"value":292950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":7179,"source":{"system":"sec-edgar","filing":"0001209191-23-030141","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123030141/doc4.xml","form_type":"4"}},{"id":1888615,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T20:07:38.000Z","date":"2023-05-15","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":29.9,"value":209300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":14179,"source":{"system":"sec-edgar","filing":"0001209191-23-030141","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123030141/doc4.xml","form_type":"4"}},{"id":2052181,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-19T00:04:33.000Z","date":"2023-01-13","kind":"grant","acquired":true,"shares":386500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2023."}],"balance_after":386500,"derivative":{"exercise_price":5.57,"expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":386500},"source":{"system":"sec-edgar","filing":"0001209191-23-003853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123003853/doc4.xml","form_type":"4"}},{"id":2052180,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-19T00:04:33.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":3691,"price":5.49,"value":20263.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $5.49 to $5.56. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,836 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2022."}],"balance_after":313106,"source":{"system":"sec-edgar","filing":"0001209191-23-003853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123003853/doc4.xml","form_type":"4"}},{"id":2052179,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-19T00:04:33.000Z","date":"2023-01-13","kind":"grant","acquired":true,"shares":64500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in four equal annual installments beginning on January 14, 2024. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,836 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2022."}],"balance_after":316797,"source":{"system":"sec-edgar","filing":"0001209191-23-003853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919123003853/doc4.xml","form_type":"4"}},{"id":2148602,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-30T20:30:36.000Z","date":"2022-09-29","kind":"sale","acquired":false,"shares":498,"price":13,"value":6474.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the trade date."}],"balance_after":250461,"source":{"system":"sec-edgar","filing":"0000899243-22-032306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924322032306/doc4.xml","form_type":"4"}},{"id":2148601,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-30T20:30:36.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":23376,"price":13.0311,"value":304614.9936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the trade date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.00 to $13.09. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":250959,"source":{"system":"sec-edgar","filing":"0000899243-22-032306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924322032306/doc4.xml","form_type":"4"}},{"id":2152599,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-22T21:32:37.000Z","date":"2022-09-21","kind":"sale","acquired":false,"shares":6126,"price":13.0129,"value":79717.0254,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the trade date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.00 to $13.07. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":274335,"source":{"system":"sec-edgar","filing":"0000899243-22-031711","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924322031711/doc4.xml","form_type":"4"}},{"id":2207963,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-13T20:03:15.000Z","date":"2022-07-11","kind":"sale","acquired":false,"shares":533,"price":56.95,"value":30354.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":7179,"source":{"system":"sec-edgar","filing":"0001209191-22-042037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919122042037/doc4.xml","form_type":"4"}},{"id":2225107,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T23:11:00.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following June 17, 2022."}],"balance_after":120000,"derivative":{"exercise_price":12.25,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-22-038532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919122038532/doc4.xml","form_type":"4"}},{"id":2225106,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-21T23:11:00.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."}],"balance_after":280461,"source":{"system":"sec-edgar","filing":"0001209191-22-038532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919122038532/doc4.xml","form_type":"4"}},{"id":2238838,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T23:28:22.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":8225,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8225,"derivative":{"exercise_price":59.39,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":8225},"source":{"system":"sec-edgar","filing":"0001209191-22-035223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919122035223/doc4.xml","form_type":"4"}},{"id":2238837,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T23:28:22.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":1160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":7712,"source":{"system":"sec-edgar","filing":"0001209191-22-035223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919122035223/doc4.xml","form_type":"4"}},{"id":2431951,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-19T21:53:23.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":251100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022."}],"balance_after":251100,"derivative":{"exercise_price":12.14,"expiration_date":"2032-01-13","underlying":"Common Stock","underlying_shares":251100},"source":{"system":"sec-edgar","filing":"0001209191-22-003759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919122003759/doc4.xml","form_type":"4"}},{"id":2431950,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-19T21:53:23.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":41900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,714 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest."}],"balance_after":260961,"source":{"system":"sec-edgar","filing":"0001209191-22-003759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919122003759/doc4.xml","form_type":"4"}},{"id":2554087,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-01T20:35:25.000Z","date":"2021-09-29","kind":"sale","acquired":false,"shares":223,"price":26.53,"value":5916.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 19,285 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest."}],"balance_after":219061,"source":{"system":"sec-edgar","filing":"0000899243-21-038637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924321038637/doc4.xml","form_type":"4"}},{"id":2554086,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-01T20:35:25.000Z","date":"2021-09-29","kind":"sale","acquired":false,"shares":8277,"price":27.2,"value":225134.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $26.65 to $27.58, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 19,285 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest."}],"balance_after":219284,"source":{"system":"sec-edgar","filing":"0000899243-21-038637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924321038637/doc4.xml","form_type":"4"}},{"id":2656902,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-23T20:05:30.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":3807,"price":26.89,"value":102370.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $26.74 to $27.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 30,856 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest."}],"balance_after":227561,"source":{"system":"sec-edgar","filing":"0000899243-21-025505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924321025505/doc4.xml","form_type":"4"}},{"id":2656901,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-23T20:05:30.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":4693,"price":26.39,"value":123848.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $25.72 to $26.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 30,856 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest."}],"balance_after":231368,"source":{"system":"sec-edgar","filing":"0000899243-21-025505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924321025505/doc4.xml","form_type":"4"}},{"id":2671518,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:33:06.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":7626,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7626,"derivative":{"exercise_price":60.96,"exercise_date":"2022-06-09","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":7626},"source":{"system":"sec-edgar","filing":"0001209191-21-040084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919121040084/doc4.xml","form_type":"4"}},{"id":2671517,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-12T00:33:06.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":1066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":6552,"source":{"system":"sec-edgar","filing":"0001209191-21-040084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919121040084/doc4.xml","form_type":"4"}},{"id":2677171,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T20:13:36.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":630,"price":62.19,"value":39179.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":5486,"source":{"system":"sec-edgar","filing":"0001209191-21-038878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919121038878/doc4.xml","form_type":"4"}},{"id":2763528,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-01T10:15:14.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":3130,"price":32.21,"value":100817.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions  reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $32.00 to $32.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 42,427 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest."}],"balance_after":236061,"source":{"system":"sec-edgar","filing":"0000899243-21-014312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924321014312/doc4.xml","form_type":"4"}},{"id":2763527,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-01T10:15:14.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":2409,"price":31.24,"value":75257.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions  reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $31.05 to $31.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 42,427 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest."}],"balance_after":239191,"source":{"system":"sec-edgar","filing":"0000899243-21-014312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924321014312/doc4.xml","form_type":"4"}},{"id":2763526,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-01T10:15:14.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":11461,"price":30.23,"value":346466.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions  reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 42,427 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest."}],"balance_after":241600,"source":{"system":"sec-edgar","filing":"0000899243-21-014312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924321014312/doc4.xml","form_type":"4"}},{"id":2799274,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-09T21:12:06.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable in 24 equal monthly installments beginning on July 2, 2011."}],"balance_after":0,"derivative":{"exercise_price":13.98,"expiration_date":"2021-06-02","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-21-018946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919121018946/doc4.xml","form_type":"4"}},{"id":2799273,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T21:12:06.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":3000,"price":65.88,"value":197640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.77 to $66.05, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6116,"source":{"system":"sec-edgar","filing":"0001209191-21-018946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919121018946/doc4.xml","form_type":"4"}},{"id":2799272,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-09T21:12:06.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":3000,"price":13.98,"value":41940.0,"ownership":{"direct":true},"balance_after":9116,"source":{"system":"sec-edgar","filing":"0001209191-21-018946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919121018946/doc4.xml","form_type":"4"}},{"id":2909364,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-12T18:26:11.000Z","date":"2021-01-08","kind":"grant","acquired":true,"shares":157500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 8, 2021."}],"balance_after":157500,"derivative":{"exercise_price":54.89,"expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":157500},"source":{"system":"sec-edgar","filing":"0000899243-21-001467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924321001467/doc4.xml","form_type":"4"}},{"id":3084208,"issuer":{"id":6346,"kind":"organization","name":"Nkarta, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-14T01:40:13.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":202400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a \"change in control\" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or \"disability\" (as described in the applicable award agreement)."}],"balance_after":202400,"derivative":{"exercise_price":18,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":202400},"source":{"system":"sec-edgar","filing":"0000899243-20-019024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000089924320019024/doc4.xml","form_type":"4"}},{"id":3113090,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T22:24:51.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":8027,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8027,"derivative":{"exercise_price":47.65,"exercise_date":"2021-06-09","expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":8027},"source":{"system":"sec-edgar","filing":"0001209191-20-036039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919120036039/doc4.xml","form_type":"4"}},{"id":3113089,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T22:24:51.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":1260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2021, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":6116,"source":{"system":"sec-edgar","filing":"0001209191-20-036039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919120036039/doc4.xml","form_type":"4"}},{"id":3118310,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T01:05:41.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":2025,"price":47.46,"value":96106.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":4856,"source":{"system":"sec-edgar","filing":"0001209191-20-035170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919120035170/doc4.xml","form_type":"4"}},{"id":3498551,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T20:39:23.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":8437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":8437,"derivative":{"exercise_price":43.54,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":8437},"source":{"system":"sec-edgar","filing":"0001209191-19-035086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919119035086/doc4.xml","form_type":"4"}},{"id":3498550,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T20:39:23.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":4134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units that vest on June 3, 2020, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":6881,"source":{"system":"sec-edgar","filing":"0001209191-19-035086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919119035086/doc4.xml","form_type":"4"}},{"id":3498549,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T20:39:23.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":782,"price":42.66,"value":33360.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":2747,"source":{"system":"sec-edgar","filing":"0001209191-19-035086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919119035086/doc4.xml","form_type":"4"}},{"id":3892202,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T23:14:21.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":4693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":4693,"derivative":{"exercise_price":38.35,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":4693},"source":{"system":"sec-edgar","filing":"0001209191-18-038193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919118038193/doc4.xml","form_type":"4"}},{"id":3892201,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T23:14:21.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":3529,"source":{"system":"sec-edgar","filing":"0001209191-18-038193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919118038193/doc4.xml","form_type":"4"}},{"id":3898116,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-11T20:33:31.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":12700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":12700,"derivative":{"exercise_price":2.5,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":12700},"source":{"system":"sec-edgar","filing":"0001171843-18-004582","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000117184318004582/formfour.xml","form_type":"4"}},{"id":3903108,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-07T00:07:27.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":771,"price":33.9,"value":26136.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":2747,"source":{"system":"sec-edgar","filing":"0001209191-18-036181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919118036181/doc4.xml","form_type":"4"}},{"id":4187353,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-10-12T18:35:30.000Z","date":"2017-10-10","kind":"sale","acquired":false,"shares":1346,"price":4.2418,"value":5709.4628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit (\"RSU\") award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 55,500 RSUs. The Reporting Person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."}],"balance_after":76188,"source":{"system":"sec-edgar","filing":"0001140361-17-038567","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117038567/doc1.xml","form_type":"4"}},{"id":4187352,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-10-12T18:35:30.000Z","date":"2017-10-10","kind":"sale","acquired":false,"shares":52,"price":4.2611,"value":221.5772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit (\"RSU\") award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 55,500 RSUs. The Reporting Person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."}],"balance_after":77534,"source":{"system":"sec-edgar","filing":"0001140361-17-038567","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117038567/doc1.xml","form_type":"4"}},{"id":4225359,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-25T00:30:56.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":1044,"price":36.15,"value":37740.6,"ownership":{"direct":true},"balance_after":3518,"source":{"system":"sec-edgar","filing":"0001209191-17-050231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919117050231/doc4.xml","form_type":"4"}},{"id":4275142,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-21T20:19:28.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 20, 2017 and the shares underlying this option will vest 100% at the earlier of (i) June 20, 2018 and (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":6666,"derivative":{"exercise_price":1.3,"expiration_date":"2027-06-19","underlying":"Common Stock, $0.001 par value","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001171843-17-003747","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000117184317003747/formfour.xml","form_type":"4"}},{"id":4278716,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-17T00:14:50.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":2714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":2714,"derivative":{"exercise_price":44.2,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":2714},"source":{"system":"sec-edgar","filing":"0001209191-17-040690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919117040690/doc4.xml","form_type":"4"}},{"id":4278715,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-17T00:14:50.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":1357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":4562,"source":{"system":"sec-edgar","filing":"0001209191-17-040690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000120919117040690/doc4.xml","form_type":"4"}},{"id":4345505,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-25T18:12:03.000Z","date":"2017-04-24","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":135000,"derivative":{"exercise_price":3.77,"expiration_date":"2027-04-23","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001140361-17-016766","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117016766/doc1.xml","form_type":"4"}},{"id":4345504,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-04-25T18:12:03.000Z","date":"2017-04-24","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 59,000 RSUs."}],"balance_after":77586,"source":{"system":"sec-edgar","filing":"0001140361-17-016766","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117016766/doc1.xml","form_type":"4"}},{"id":4357944,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-04-05T19:38:27.000Z","date":"2017-04-04","kind":"sale","acquired":false,"shares":6425,"price":9.0582,"value":58198.935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,000 restricted stock units (\"RSUs\").  The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,736 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017."}],"balance_after":32586,"source":{"system":"sec-edgar","filing":"0001140361-17-015045","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117015045/doc1.xml","form_type":"4"}},{"id":4357943,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-04-05T19:38:27.000Z","date":"2017-04-04","kind":"sale","acquired":false,"shares":48,"price":8.8671,"value":425.6208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,000 restricted stock units (\"RSUs\").  The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,736 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017."}],"balance_after":39011,"source":{"system":"sec-edgar","filing":"0001140361-17-015045","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117015045/doc1.xml","form_type":"4"}},{"id":4495031,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-09T17:55:08.000Z","date":"2017-01-06","kind":"exercise","acquired":false,"shares":21369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 30, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable, subject to an annual limitation of 175,438 shares that can be issued to a single grantee upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":1.43,"expiration_date":"2017-01-11","underlying":"Common Stock","underlying_shares":21369},"source":{"system":"sec-edgar","filing":"0001140361-17-001260","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117001260/doc1.xml","form_type":"4"}},{"id":4495030,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-09T17:55:08.000Z","date":"2017-01-05","kind":"exercise","acquired":false,"shares":21369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 30, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable, subject to an annual limitation of 175,438 shares that can be issued to a single grantee upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan."}],"balance_after":21369,"derivative":{"exercise_price":1.43,"expiration_date":"2017-01-11","underlying":"Common stock","underlying_shares":21369},"source":{"system":"sec-edgar","filing":"0001140361-17-001260","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117001260/doc1.xml","form_type":"4"}},{"id":4495029,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-01-09T17:55:08.000Z","date":"2017-01-06","kind":"sale","acquired":false,"shares":21369,"price":8.515,"value":181957.035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 30, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $8.22 to $8.72, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,875 restricted stock units.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit."}],"balance_after":37323,"source":{"system":"sec-edgar","filing":"0001140361-17-001260","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117001260/doc1.xml","form_type":"4"}},{"id":4495028,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-01-09T17:55:08.000Z","date":"2017-01-06","kind":"exercise","acquired":true,"shares":21369,"price":1.43,"value":30557.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 30, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,875 restricted stock units.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit."}],"balance_after":58692,"source":{"system":"sec-edgar","filing":"0001140361-17-001260","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117001260/doc1.xml","form_type":"4"}},{"id":4495027,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-01-09T17:55:08.000Z","date":"2017-01-05","kind":"sale","acquired":false,"shares":21369,"price":8.1708,"value":174601.8252,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 30, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $8.06 to $8.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,875 restricted stock units.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit."}],"balance_after":37323,"source":{"system":"sec-edgar","filing":"0001140361-17-001260","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117001260/doc1.xml","form_type":"4"}},{"id":4495026,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-01-09T17:55:08.000Z","date":"2017-01-05","kind":"exercise","acquired":true,"shares":21369,"price":1.43,"value":30557.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 30, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,875 restricted stock units.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit."}],"balance_after":58692,"source":{"system":"sec-edgar","filing":"0001140361-17-001260","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117001260/doc1.xml","form_type":"4"}},{"id":4498239,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-05T19:09:32.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of the date of grant, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":176000,"derivative":{"exercise_price":7.66,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0001140361-17-000853","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036117000853/doc1.xml","form_type":"4"}},{"id":4576806,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-20T11:56:01.000Z","date":"2016-10-18","kind":"grant","acquired":true,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 18, 2016 and will vest annually over a three-year period measured from the date of grant."}],"balance_after":13333,"derivative":{"exercise_price":9,"expiration_date":"2026-10-17","underlying":"Common Stock, $0.001 par value","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001171843-16-012533","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1309702/000117184316012533/formfour.xml","form_type":"4"}},{"id":4581439,"issuer":{"id":158190,"kind":"organization","name":"OncoMed Pharmaceuticals Inc","symbol":"OMED"},"owners":[{"id":36279,"kind":"person","name":"HASTINGS PAUL J","position":1,"cik":"0001309702","reported_name":"HASTINGS PAUL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2016-10-11T21:43:25.000Z","date":"2016-10-09","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\").  The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,875 restricted stock units and 1,298 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016."}],"balance_after":37323,"source":{"system":"sec-edgar","filing":"0001140361-16-082541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302573/000114036116082541/doc1.xml","form_type":"4"}}]}